Insider trade

Argan, Inc. (AGX): Director sold ~$34K

William F. Leimkuhler, Director at Argan, Inc., sold ~$34K of Argan, Inc. shares.

~$34K
Approx. value · 100 sh @ $337.93
900
Holds after · shares reported
Traded
Dec 23, 2025
Filed
Dec 29, 2025

What stands out in this filing

  • The sale was 10.0% of the shares this insider held before it; the filing reports 900 shares, held indirectly afterwards.
  • 100 shares at an average of $337.93 each, as reported on the form.
  • No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 4, 2025Company filing · Form 8-K · ResultsReported its results
  2. Dec 10, 2025InsiderDirector sold ~$328K of AGX shares in the open market
  3. Dec 23, 2025 · this disclosureInsiderDirector sold ~$34K of AGX shares in the open market

What came next

  1. Dec 23, 2025InsiderDirector sold ~$34K of AGX shares in the open market
  2. Jan 7, 2026InsiderDirector sold ~$1.31M of AGX shares in the open market
  3. Jan 8, 2026InsiderDirector sold ~$2.07M of AGX shares in the open market
  4. Jan 12, 2026InsiderDirector sold ~$689K of AGX shares in the open market
  5. Jan 13, 2026InsiderDirector sold ~$1.35M of AGX shares in the open market
  6. Jan 16, 2026Insider · Their largest sale since 2016Director sold ~$4.19M of AGX shares in the open market
  7. Jan 20, 2026InsiderDirector sold ~$1.03M of AGX shares in the open market
  8. Jan 21, 2026Insider · Their largest sale since 2015Director sold ~$7.35M of AGX shares in the open market
  9. Jan 27, 2026Insider · Their largest sale since 2024Director sold ~$1.8M of AGX shares in the open market
  10. Mar 26, 2026Company filing · Form 8-K · ResultsReported its results
  11. Mar 31, 2026Insider · Their largest sale since 2024Director sold ~$2.46M of AGX shares in the open market
  12. Apr 2, 2026InsiderDirector sold ~$1.43M of AGX shares in the open market
  13. Apr 13, 2026Insider · Their largest sale since 2016Director sold ~$5.05M of AGX shares in the open market
  14. Apr 16, 2026InsiderCFO sold ~$363K of AGX shares in the open market
  15. Apr 17, 2026Insider · Their largest sale since 2017CEO sold ~$11.6M of AGX shares in the open market
  16. Apr 20, 2026InsiderCEO sold ~$1.52M of AGX shares in the open market
  17. Apr 21, 2026Insider · 2 peopleInsiders: 2 sales (~$9.1M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Argan, Inc.

For Argan, Inc., OQRO holds 3 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AGX page.

Other recent filings by William F. Leimkuhler, Director

The full history of William F. Leimkuhler, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Argan, Inc. (AGX) insider traded, and how much?

William F. Leimkuhler, Director at Argan, Inc., sold ~$34K of Argan, Inc. shares. 100 shares at $337.93.

When did it happen, and when was it made public?

Traded: Dec 23, 2025. Filed: Dec 29, 2025. That is 6 days between the two dates.

What stands out in this filing?

The sale was 10.0% of the shares this insider held before it; the filing reports 900 shares, held indirectly afterwards. 100 shares at an average of $337.93 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Argan, Inc. recently?

For Argan, Inc., OQRO holds 3 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days. They are listed on the AGX page.

Does this mean AGX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Argan, Inc.

Everything OQRO holds on this company is on its AGX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data